The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.
Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.
Two people charged after breaking into a Corner Brook home and using a weapon to assault the resident
St. John's man charged with murder after suspicious death in the capital city
Corner Brook RNC launch new dedicated traffic unit at a checkpoint in Meadows this morning
Western Regional Waste Management gets big uptake in people using new app for sorting trash
Integrated Youth Services Hub opening next year in Corner Brook, will be operated out of Vine Place Community centre
